Company intelligence / Profile preview
OCT Therapies and Research
- Ownership
- Private
- Development stage
- Other
Overview
OCT Therapies and Research is a biotechnology company focused on the development of advanced cell-based therapies to treat chronic and degenerative diseases. The company specializes in the isolation, expansion, and clinical application of mesenchymal stem cells (MSCs) derived from various human tissues. Their primary research and development efforts target high-unmet-need conditions such as critical limb ischemia, diabetic foot ulcers, and orthopedic injuries. By leveraging proprietary processing techniques, OCT Therapies aims to provide regenerative medicine solutions that improve patient outcomes and reduce the burden of chronic disability.
- Therapeutic areas
- CardiovascularNeurologyEndocrinologyRheumatologyImmunology
- Modalities
- Cell therapyStem cell therapyMesenchymal stem cells
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on OCT Therapies and Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OCT Therapies and Research.